Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy

ObjectiveThe impact of thrombus migration (TM) prior to endovascular thrombectomy (EVT) on clinical outcomes and revascularisation rates remains unknown. We aimed to examine whether preinterventional TM modifies the treatment effects of direct EVT versus bridging EVT in acute large vessel occlusion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke and vascular neurology 2024-04, Vol.9 (2), p.126-133
Hauptverfasser: Tan, ZeFeng, Zhang, Lei, Huang, Li'an, Qiao, Hongyu, Guan, Min, Yang, Bing, Yang, Pengfei, Zhang, Yongwei, Shen, Hongjian, Zhou, Yu, Hong, Bo, Shi, Huaizhang, Han, Hongxing, Leng, Xinyi, Dong, Yi, Lian, Changlin, Chen, Wenhuo, Xu, Anding, Liu, Jianmin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectiveThe impact of thrombus migration (TM) prior to endovascular thrombectomy (EVT) on clinical outcomes and revascularisation rates remains unknown. We aimed to examine whether preinterventional TM modifies the treatment effects of direct EVT versus bridging EVT in acute large vessel occlusion patients.MethodsAll patients undergoing catheter angiography in the Direct Intra-arterial thrombectomy in order to Revascularise acute ischaemic stroke patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals: A Multicentre randomised clinical Trial were included. TM was determined by radiologists unaware of the study by analysing discrepancies between computed tomographic angiography at baseline and first-run digital subtraction angiography before EVT. The primary outcome was the score on the modified Rankin scale (mRS) assessed at 90 days.ResultsOf 627 included patients, the TM rate was 11.3% (71/627). In the multivariable logistic regression model, baseline National Institutes of Health Stroke Scale score (adjusted OR 0.956, 95% CI 0.916 to 0.999; p=0.043) and intravenous thrombolysis (adjusted OR 2.614, 95% CI 1.514 to 4.514; p
ISSN:2059-8688
2059-8696
DOI:10.1136/svn-2022-002257